|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 477.26 EGP | +20.00% |
|
+65.88% | +649.82% |
| 05-17 | GlaxoSmithKline Q1 consol net profit EGP 4.7 million | RE |
| 03-12 | GlaxoSmithKline S.A.E Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +20.00% | +65.88% | +548.45% | +563.05% | +649.82% | +887.09% | +1,418.97% | +1,353.73% | +4,176.52% | 800M | |
| -0.52% | +3.21% | -2.57% | +25.02% | +10.33% | +89.52% | +125.32% | +343.82% | +1,354.86% | 1,057B | |
| +0.88% | +1.13% | +0.05% | +17.13% | +25.27% | +49.56% | +49.79% | +49.24% | +110.03% | 625B | |
| +0.89% | -1.95% | -1.55% | +22.07% | +7.68% | +24.23% | +63.19% | +115.71% | +268.54% | 435B | |
| +0.64% | +3.71% | +9.69% | +15.59% | +12.49% | +49.90% | +38.33% | +1.19% | +49.17% | 363B | |
| -0.11% | +1.01% | +1.19% | +10.61% | +14.74% | +30.97% | +38.84% | +48.28% | +56.32% | 296B | |
| +0.03% | +3.48% | -7.28% | -11.86% | -13.71% | +7.83% | +6.61% | +46.03% | +130.62% | 249B | |
| +1.51% | +6.69% | +13.01% | +23.89% | +25.55% | +42.58% | +58.47% | +80.33% | +138.81% | 222B | |
| -1.18% | -0.10% | -6.28% | +0.67% | -7.15% | -6.39% | -51.60% | -4.58% | +89.70% | 209B | |
| +1.80% | +2.30% | -1.21% | +1.43% | +8.53% | +11.56% | +66.16% | +94.58% | +67.92% | 165B | |
| +2.14% | +7.00% | +10.35% | +4.21% | +7.47% | +8.87% | -25.33% | -41.80% | -23.72% | 153B | |
| +0.89% | -0.90% | +11.70% | +15.24% | +19.99% | +40.85% | +6.76% | -3.95% | +5.05% | 132B | |
| +2.49% | +3.98% | -0.09% | +15.41% | +9.42% | +35.34% | +43.74% | +147.54% | +382.42% | 126B | |
| -2.24% | +0.29% | -2.37% | +3.82% | +4.96% | +36.40% | +38.01% | +5.95% | -9.75% | 106B | |
| +0.07% | +1.14% | -1.15% | +2.91% | -8.91% | -7.36% | -23.00% | -12.96% | +5.81% | 104B | |
| +3.72% | +6.36% | -3.75% | -10.57% | -13.72% | +15.10% | +66.71% | +74.48% | +492.67% | 71.54B | |
| -0.97% | +4.88% | -1.40% | +33.28% | +33.53% | +92.22% | -6.21% | +4.50% | -49.27% | 56.57B | |
| +0.76% | +3.22% | +4.16% | +8.14% | +15.45% | +28.47% | +25.38% | +54.07% | +17.17% | 56.09B | |
| +4.82% | +1.00% | -1.78% | +3.45% | -8.31% | -10.44% | +35.84% | -4.04% | +227.78% | 53.41B | |
| -1.19% | +0.69% | +0.83% | +11.53% | -2.67% | +3.40% | +8.52% | - | - | 43.91B | |
| Average | +1.55% | +3.36% | +28.50% | +37.75% | +39.54% | +71.48% | +99.23% | +123.80% | +394.24% | 226.19B | |
| Weighted average by Cap. | +0.29% | +1.54% | +0.68% | +14.66% | +10.49% | +43.74% | +54.09% | +116.87% | +410.47% |
- Stock Market
- Stocks
- BIOC Stock
- Sector GlaxoSmithKline S.A.E
Select your edition
All financial news and data tailored to specific country editions
